CAR-T

Pinned Content Last updated 2 years ago

CAR-T therapies are progressing to the market at a much faster rate. Novartis just received approval from Australian authorities to make it's CAR-T therapy available to all eligible patients. Additionally, Bristol-Myers Squibb also received FDA approval in the US for it's CAR-T cell therapy for adults with relapsed large B-cell lymphoma. Kite Pharma already has FDA approved CAR-T cell therapy for the same in the market for a while now. Seems like all major Pharma/Biotech companies will soon embrace CAR-T's, leading to more competition and hopefully making these therapies more affordable as a result. Below is a link to the latest advancements in CAR-T's by biopharma reporter.
Links
https://www.biopharma-reporter.com/Article/2021/02/15/Scientific-breakthroughs-approvals-Latest-CAR-T-cell-therapy-related-developments#:~:text=Earlier%20this%20month%2C%20the%20US,directed%20CAR%20T%2Dcell%20immunotherapy.

Archived Board

CAR-T's discussion
Pinned Content
Here is a link to a very interesting Nature review article on programming CAR-T cells to kill cancer!
Links
https://www.nature.com/articles/s41551-018-0235-9
Archived Board Archived Date Discussions
CAR-T's discussion 12

4 members


Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started